Other Medical Weight Loss Solutions While GLP-1 agonists show promise, they are not the only weight loss medications available
Both were developed in Russia, both influence neurotransmitter systems in the brain, and both are used by people looking to improve mental performance or reduce anxiety
Hoofnagle, Funding: National Institutes of Health, Canadian Institutes of Health Research, Borden Scholars, and Helmsley Charitable Trust Foundation
Pharmacy Transparency Your provider must disclose: Which pharmacy compounds or dispenses your peptides (name and location) Pharmacy type (503A or 503B) and FDA registration status Quality testing performed (purity, sterility, endotoxin testing) Certificates of Analysis available upon request Sourcing of raw peptide materials (US-manufactured preferred) Warning sign: Providers who are evasive about pharmacy sourcing or claim proprietary pharmacy relationships are likely using questionable sources
AOD-9604 selectively decreases fat without damaging lean muscular tissue since it specifically targets adipose cells
Dermatology clinicians are increasingly caring for patients on GLP-1s or prescribing the therapy in their own practice
